Clinical Trial Update: Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating epcoritamab versus observation in B-cell lymphoma patients not in complete remission after CD19-directed CAR-T therapy; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma Not Otherwise Specified
• Mediastinal Large B-cell Lymphoma
• Transformed Indolent B-cell Non-hodgkin Lymphoma to Diffuse Large B-cell Lymphoma

Drugs mentioned

• Epcoritamab (epcoritamab)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Primary Mediastinal Large B-Cell Lymphoma | Phase 2 | Status: RECRUITING